Cisplatin resistance driver gene CLSPN product is a target for immunotherapy in urothelial carcinoma.
Ontology highlight
ABSTRACT: Cisplatin resistance driver gene CLSPN product is a target for immunotherapy in urothelial carcinoma.
PROVIDER: PRJNA898969 | ENA |
REPOSITORIES: ENA
ACCESS DATA